HCPCS Level II A0429: Ambulance BLS Emergency Transport
HCPCS Level II code A0429 represents ambulance service for basic life support emergency transport (BLS‑emergency). This code is used nationally to bill for ground ambulance responses that provide noninvasive, basic emergency care and transport when a patient requires urgent but BLS‑level care. The code matters because ambulance utilization and emergent transports are central to regional emergency response systems, influence EMS provider revenue, and intersect with payer policies on medical necessity and destination decisions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find contextual clinical information about typical BLS emergency scenarios, an outline of common ICD‑10 presenting diagnoses associated with BLS transport, comparisons to related ambulance codes, and the common modifiers used to indicate transport circumstances. The publication also highlights billing considerations and benchmarks that affect coverage and claim adjudication for ground emergency transports.
This summary serves clinicians, billing professionals, and policy analysts seeking a concise reference on HCPCS Level II code A0429, its clinical role in emergency medical services, and the payer landscape impacting reimbursement and coverage decisions at a national level.
Customize your policy alerts
Sign up for hcpcs A0429 policy alerts
Get alerted when payer policies referencing A0429 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code A0429 describes ambulance service, basic life support, emergency transport (BLS‑emergency). The service type is Basic Life Support (BLS) emergency transport, typically provided by ground ambulance crews trained to deliver basic emergency medical care. The typical site of service is ground ambulance transport from the scene or between facilities during an emergency, with patient care focused on stabilization, basic airway management, bleeding control, and noninvasive interventions. If additional contextual details are not provided, Data not available in the input.
National Reimbursement Benchmarks
National commercial benchmarks for HCPCS A0429 cluster around the BUCA average commercial rate of $385.10, providing a useful mid-market reference. Blue Cross Blue Shield shows the highest dispersion with a P75–P25 spread of $527.70 ($506.60 minus $303.90), indicating wide variability in negotiated rates, while Aetna is notably tighter with a spread of $41.00 ($266.00 minus $225.00). Cigna and UnitedHealth Group show intermediate dispersion of $241.70 ($446.60 minus $205.90) and $119.40 ($460.60 minus $341.20), respectively, highlighting meaningful differences in rate consistency across major national payers.
Focusing on central tendency, UnitedHealth Group and Blue Cross Blue Shield have higher mean levels ($438.60 and $460.50) relative to BUCA’s $385.10 average, while Cigna’s mean sits at $319.70 and Aetna at $246.10. These contrasts between means and BUCA’s average, combined with the dispersion measures, illustrate where negotiated rates are both higher and more volatile (Blue Cross Blue Shield, UnitedHealth Group) versus more clustered and predictable (Aetna).